Echinacoside protects against MPTP/MPP+-induced neurotoxicity via regulating autophagy pathway mediated by Sirt1
Open Access
- 13 November 2018
- journal article
- research article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 34 (1) , 203-212
Abstract
Parkinson’s disease (PD) is a common chronic neurodegenerative disease and greatly affects the quality of PD patients’ life. Current symptomatic treatment of PD is limited. There are no effective treatment and drugs that could radically cure PD. Increasing experimental evidence has proven a causal relationship between alpha-synuclein (α-synuclein, α-syn) and the neuropathology of Parkinson’s diseases, although the exact pathophysiological role of α-synuclein is not fully clarified. Previous studies showed that monomers and polymers of α-synuclein were secreted from damaged nerve cells via exocytosis and occupied healthy nerve cells via endocytosis, which afford evidence for the prion-like role of α-synuclein. Autophagy is the known mechanism for eukaryotic cells to degrade protein polymers and damaged organelles that proteasome does not cope with. Therefore, promoting the clearance of α-synuclein by enhancing autophagy in neuronal cells could be a promising treatment in the early stage of PD. SIRT1 is a potent regulator of autophagy, because it deacetylates a mass of important transcription factors such as Forkhead Box subgroup O (FoxO) transcription factors family. SIRT1’s action relates to FoxO, because FoxO transcription factors are involved in various molecular pathways underlying neuronal protection and autophagy. Moreover, Sirt1 deacetylates proautophagic proteins such as Atg5, Atg7, and Atg8. Echinacoside (ECH) is the main active ingredient of a widely used Chinese herb cistanche, which has been proven to elicit neuroprotective effects in models of neurodegenerative diseases. In this study, we found that ECH could improve PD-like symptoms in MPTP-lesioned mouse model. We further showed that the underlying mechanism of the action of ECH was associated with enhancing autophagy in neurons via bind to Sirt1 directly and affect FoxO expression. Our study demonstrated ECH as a potential therapeutic agent against PD.Keywords
Funding Information
- Centers for Disease Control and Prevention (201707)
- Nanjing Medical Science and Technology Development Project (YKK17149)
- Natural Science Foundation of Jiangsu Province (BK20170769)
- National Natural Science Foundation of China (81703483, 81603089)
This publication has 32 references indexed in Scilit:
- Parkinson’s disease and pesticides: A meta-analysis of disease connection and genetic alterationsBiomedicine & Pharmacotherapy, 2017
- Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: Future applications in Parkinson’s diseaseBiomedicine & Pharmacotherapy, 2017
- Corynoxine, a Natural Autophagy Enhancer, Promotes the Clearance of Alpha-Synuclein via Akt/mTOR PathwayJournal of Neuroimmune Pharmacology, 2014
- SIRT1 in Neurodevelopment and Brain SenescenceNeuron, 2014
- Amelioration of Dextran Sulphate Sodium‐Induced Colitis in Mice by Echinacoside‐Enriched Extract of Cistanche tubulosaPhytotherapy Research, 2013
- SIRT1 and SIRT2: emerging targets in neurodegenerationEMBO Molecular Medicine, 2013
- The neurobiology of sirtuins and their role in neurodegenerationTrends in Pharmacological Sciences, 2012
- Echinacoside prevents the striatal extracellular levels of monoamine neurotransmitters from diminution in 6-hydroxydopamine lesion ratsJournal of Ethnopharmacology, 2007
- Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's diseaseEuropean Journal of Pharmacology, 2007
- A new motor test sensitive to aging and dopaminergic functionJournal of Neuroscience Methods, 1991